Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML

NCT00529880 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

19

Enrollment

NETWORK

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Fludarabine , cytarabine

Sponsor

Cooperative Study Group A for Hematology